Business Segments · D&A
Orthopaedics — D&A
Stryker Orthopaedics — D&A increased by 6.7% to $111.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric declined by 0.9%, from $112.00M to $111.00M. Over 2 years (FY 2022 to FY 2024), Orthopaedics — D&A shows an upward trend with a 11.2% CAGR.
Analysis
StatementSegment
CategoryEfficiency
SignalContext dependent
VolatilityStable
First reportedQ1 2022
Last reportedQ3 2025
Rolls up toD&A
How to read this metric
An increase often reflects significant recent capital investment or the amortization of acquired technology assets.
Detailed definition
This represents the non-cash allocation of the cost of tangible and intangible assets used by the Orthopaedics segment o...
Peer comparison
Commonly reported as part of segment-level operating performance in capital-intensive healthcare sectors.
Metric ID:
syk_segment_orthopaedics_depreciation_and_amortizationHistorical Data
15 periods
| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $87.50M | $87.50M | $87.50M | $87.50M | $96.50M | $96.50M | $96.50M | $96.50M | $108.00M | $105.00M | $112.00M | $108.00M | $98.00M | $104.00M | $111.00M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +10.3% | +0.0% | +0.0% | +0.0% | +11.9% | -2.8% | +6.7% | -3.6% | -9.3% | +6.1% | +6.7% |
| YoY Change | — | — | — | — | +10.3% | +10.3% | +10.3% | +10.3% | +11.9% | +8.8% | +16.1% | +11.9% | -9.3% | -1.0% | -0.9% |
Range$87.50M – $112.00M
CAGR+7.0%
Avg YoY Growth+7.2%
Median YoY Growth+10.3%
Current Streak2 quarters growth
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Stryker's orthopaedics — d&a?
- Stryker (SYK) reported orthopaedics — d&a of $111.00M in Q3 2025.
- How has Stryker's orthopaedics — d&a changed year-over-year?
- Stryker's orthopaedics — d&a decreased by 0.9% year-over-year, from $112.00M to $111.00M.
- What is the long-term trend for Stryker's orthopaedics — d&a?
- Over 2 years (2022 to 2024), Stryker's orthopaedics — d&a has grown at a 11.2% compound annual growth rate (CAGR), from $350.00M to $433.00M.
- What does orthopaedics — d&a mean?
- The non-cash expense representing the aging of assets used in the orthopedic business.